Profile
Tom Luby worked as a Biology Director at MGI PHARMA, Inc. from 2004 to 2008.
He then worked as a Senior Director at Shire Human Genetic Therapies, Inc. from 2010 to 2013.
After that, he worked as an Area Head at Eisai Research Institute of Boston, Inc. from 2008 to 2009.
From 2017 to 2019, he was the Head-JLABS at Johnson & Johnson.
Mr. Luby holds a doctorate degree from Tufts University and an undergraduate degree from State University of New York at Albany.
Former positions of Tom Luby
| Companies | Position | End |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 2018-12-31 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 2012-12-31 |
| Eisai Research Institute of Boston, Inc. | Corporate Officer/Principal | 2008-12-31 |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Corporate Officer/Principal | 2007-12-31 |
Training of Tom Luby
| Tufts University | Doctorate Degree |
| State University of New York at Albany | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private companies | 3 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
| Eisai Research Institute of Boston, Inc. | Transportation |
- Stock Market
- Insiders
- Tom Luby